Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

784 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
Williams B, Lacy PS, Cruickshank JK, Collier D, Hughes AD, Stanton A, Thom S, Thurston H; CAFE and ASCOT Investigators. Williams B, et al. Among authors: stanton a. Circulation. 2009 Jan 6;119(1):53-61. doi: 10.1161/CIRCULATIONAHA.108.785915. Epub 2008 Dec 22. Circulation. 2009. PMID: 19103995 Clinical Trial.
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Williams B, et al. Among authors: stanton a. Circulation. 2006 Mar 7;113(9):1213-25. doi: 10.1161/CIRCULATIONAHA.105.595496. Epub 2006 Feb 13. Circulation. 2006. PMID: 16476843 Clinical Trial.
Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of Anglo-Scandinavian Cardiac Outcomes Trial.
Davies JE, Lacy P, Tillin T, Collier D, Cruickshank JK, Francis DP, Malaweera A, Mayet J, Stanton A, Williams B, Parker KH, McG Thom SA, Hughes AD. Davies JE, et al. Among authors: stanton a. Hypertension. 2014 Jul;64(1):60-8. doi: 10.1161/HYPERTENSIONAHA.113.02838. Epub 2014 May 12. Hypertension. 2014. PMID: 24821941 Free PMC article. Clinical Trial.
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.
Lafeber M, Spiering W, Visseren FL, Grobbee DE, Bots ML, Stanton A, Patel A, Prabhakaran D, Webster R, Thom S, Rodgers A; UMPIRE investigators. Lafeber M, et al. Among authors: stanton a. Eur J Prev Cardiol. 2017 Jun;24(9):951-961. doi: 10.1177/2047487317695616. Epub 2017 Mar 8. Eur J Prev Cardiol. 2017. PMID: 28436727 Clinical Trial.
Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
Stolk RP, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Juming L, Patel A, Thom SA, Grobbee DE; AdRem project team and ADVANCE management committee. Stolk RP, et al. Among authors: stanton a. Contemp Clin Trials. 2007 Jan;28(1):6-17. doi: 10.1016/j.cct.2006.08.011. Epub 2006 Sep 3. Contemp Clin Trials. 2007. PMID: 17030155 Free article. Clinical Trial.
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudy.
Stettler C, Witt N, Tapp RJ, Thom S, Allemann S, Tillin T, Stanton A, O'Brien E, Poulter N, Gallimore JR, Hughes AD, Chaturvedi N. Stettler C, et al. Among authors: stanton a. Diabetes Care. 2009 Jun;32(6):1098-100. doi: 10.2337/dc08-2137. Epub 2009 Feb 24. Diabetes Care. 2009. PMID: 19244088 Free PMC article.
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
Beulens JW, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA, Grobbee DE, Stolk RP; AdRem project team; ADVANCE management committee. Beulens JW, et al. Among authors: stanton a. Diabetologia. 2009 Oct;52(10):2027-36. doi: 10.1007/s00125-009-1457-x. Epub 2009 Jul 25. Diabetologia. 2009. PMID: 19633827 Free article. Clinical Trial.
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy.
Barron AJ, Hughes AD, Sharp A, Baksi AJ, Surendran P, Jabbour RJ, Stanton A, Poulter N, Fitzgerald D, Sever P, O'Brien E, Thom S, Mayet J; ASCOT Investigators. Barron AJ, et al. Among authors: stanton a. Hypertension. 2014 Feb;63(2):252-8. doi: 10.1161/HYPERTENSIONAHA.113.01360. Epub 2013 Nov 11. Hypertension. 2014. PMID: 24218432 Clinical Trial.
784 results